New blood test could reveal Cancer's next move
NCT ID NCT06678724
Summary
This study aims to learn if a new type of blood test can predict how recurrent or metastatic head and neck cancer will progress. Researchers will analyze blood samples from 30 patients to look for specific cancer cells and immune cells. The goal is to see if these findings can help forecast a patient's response to treatment and overall outlook.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT HEAD AND NECK SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-••••
Locations
-
National Taiwan University HsinChu Branch
RECRUITINGZhubei, HsinChu County, 302058, Taiwan
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.